key: cord-0862420-frrje8us
authors: Bertoncelli Tanaka, M; St John, E R; Exarchos, G; Hogben, K; Ahmed, H U; Hrouda, D
title: Safety and adverse events of urgent elective surgery during COVID-19 within three UK hospitals
date: 2020-12-21
journal: Br J Surg
DOI: 10.1093/bjs/znaa058
sha: 29ba2d58e51382635d836033b326603a6e726c6c
doc_id: 862420
cord_uid: frrje8us

This is a cohort study including 283 patients who underwent breast and urological procedures in three UK centres during the peak of COVID-19. COVID-related 30-day mortality was zero, as well as COVID-related admissions. Only 12 patients developed COVID-19 symptoms, although none had a positive COVID swab. Non-emergency surgery for breast and urological conditions was safe during the peak of the COVID-19 pandemic, provided contemporaneous safety measures were followed.

COVID-19 significantly affected the provision of surgical treatment worldwide 1 . This report is on COVID-19-related adverse events following elective surgery in three hospitals 16/03/2020 -30/05/2020. During the period in question guidelines for conducting surgery changed on a regular basis but urgent surgery were permitted. The study was approved as an audit (URO_07) by Imperial College Healthcare NHS Trust. Data was collected from electronic medical records and through telephone review with patients. Of 283 patients with a mean age of 61.9 (IQR 54-72), one third were female and 62 per cent of the total had cancer-related procedures (41 breast and 242 urology). Population demographics are detailed in Table 1 .

Most operations were considered complex (207 or 70 per cent), with 14 per cent intermediate and 16 per cent low complexity. In total, 150 (53 per cent) had a negative pre-op COVID swab whilst the remaining 47 per cent were not COVID swab tested due to reduced exam availability at the beginning of the pandemic. The overall complication rate was 10 per cent (30/280): grades I (77 per cent), II (4/30) and III (3/30). One death was reported within 30 days; an 82 year old patient developed hyperkalemia and sudden cardiac arrest 8 days following bilateral ureteric stent change. He did not develop COVID-related symptoms. Telephone consultation 30-45 days after surgery was able to review 280 (99 per cent) patients. Of these, only 12 (4 per cent) described COVID-related symptoms, including cough (n ¼ 3), fever (n ¼ 2), mild shortness of breath (n ¼ 1), malaise (n ¼ 3); there were no specific symptoms documented in 3. None of these patients required hospital admission due to COVID-19 symptoms and recovered completely within 2 weeks. Only four (1.4 per cent) required readmission to the hospital within 30 days but none had a positive COVID-19 swab.

Dr Bertoncelli Tanaka had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. 

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans